Stephen Hanauer to Drug Synergism
This is a "connection" page, showing publications Stephen Hanauer has written about Drug Synergism.
Connection Strength
0.138
-
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk? Gut. 2007 Sep; 56(9):1181-3.
Score: 0.070
-
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):209-14.
Score: 0.068